PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)

CUSIP: 69366J200

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class
Equity / Common Stock, $0.001 par value per share
Total 13F shares
78,779,105
Total 13F value
$4,025,030,193
Holder snapshot 6 visible 7 signals
Share change
+1,101,924
Put/Call ratio
70%
SEC-reported price per share
$50.96
Number of holders
260
Value change
+$67,568,904
Number of buys
133
Open additional details 1 more signal available
Number of sells
117
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
81,782,297

Security key

69366J200

Report period

Q1 2025

Institutions

260

Top holders

10

PTCT full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2025 Previous quarter: Q4 2024 PTC THERAPEUTICS, INC. SEC filings PTC THERAPEUTICS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F 13D/G Lead comparable stake: 6.9% 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 6.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership Top 5
ARMISTICE CAPITAL, LLC 6.9%
Camber Capital Management LP 4.2%
VANGUARD GROUP INC 11%
BlackRock, Inc. 9.7%
RTW INVESTMENTS, LP 9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
13F 13D/G
Company
13F 13D/G
6.9%
from 13D/G
$287,902,920
6,378,000 shares
 — 31 Dec 2024
Camber Capital Management LP
13D/G 13F
Company
13D/G 13F
4.2%
$158,464,000
3,200,000 shares
 $0 31 Dec 2024
VANGUARD GROUP INC
13F
Company
13F
11%
$414,332,026
9,178,822 shares
 — 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
9.7%
$356,551,878
7,898,801 shares
 — 31 Dec 2024
RTW INVESTMENTS, LP
13F
Company
13F
9%
$333,725,753
7,393,127 shares
 — 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
5.9%
$216,090,731
4,787,123 shares
 — 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
260
Shares
78,779,105
Rows available
260
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
237
Q1 2025 holders
260
Holder diff
23
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .